WHO Interim Guidance on Clinical Management of Suspected SARI with Novel Coronavirus: Do's and Don'ts

This interim guidance is intended to assist clinicians in the management of patients with severe infections who may develop acute respiratory failure or septic shock. The guidance lists interventions that may be beneficial to patients and interventions that should not be undertaken.


WHO Interim Guidance on Clinical Management of Suspected SARI with Novel Coronavirus: Do's and Don'ts - cover page
Brand
WHO
Category
Health Care
Document type
Other
Language
Japanese
Pages
18
File format
PDF
File size
415 KB
Published
03 November, 2023
Updated
03 November, 2023
MD5 checksum
E58A029FD13CD2547E67A82808D8111E

About this manual

This is a Japanese translation of a World Health Organization interim guidance document on the clinical management of suspected severe acute respiratory infection (SARI) with novel coronavirus infection. It is organized into four sections: early detection and management; management of severe dyspnea, hypoxemia and ARDS; management of septic shock; and prevention of complications. The document uses symbols for Do, Don't and procedures requiring caution.

The guidance is intended for clinicians caring for patients with severe manifestations of SARI, including doctors working in intensive care units with limited equipment for mechanical ventilation, invasive hemodynamic monitoring or blood gas analysis. It states that all confirmed cases reported to date were adults and that management for children may be added later. References and acknowledgements are included. This manual is written in Japanese.

What's inside

  • Introduction
  • Section 1: Early detection and management
  • Section 2: Management of severe dyspnea, hypoxemia and ARDS
  • Section 3: Management of septic shock
  • Section 4: Prevention of complications
  • Clinical syndrome definitions (Table 1)
  • Infection prevention and control measures (Table 2)
  • References
  • Acknowledgements

Frequently asked questions

What oxygen saturation target is recommended for patients with severe dyspnea or hypoxemia?

For significant dyspnea, hypoxemia with SpO2 below 90%, or shock, oxygen should be given and the dose set to a target SpO2 of 92–95%.

Were all reported confirmed cases adults?

Yes. The guidance says all confirmed cases reported to date were adults, so it focuses on care for adolescents and adults.

How long is the interim guidance valid?

The interim guidance is valid for 12 months from the date it is publicly announced.

Download PDF (415 KB)

More WHO Manuals


View all WHO manuals →